Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dove Keith

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
JCO Precision Oncology|May 26, 2021
Tumor-Infiltrating Leukocyte Phenotypes Distinguish Outcomes in Related Patients With Pancreatic AdenocarcinomaJason M Link, Shannon M Liudahl, Courtney B Betts, et al.
International Journal of Cancer|June 16, 2026
Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE ConsortiumChristine Worthington, Maria Raitses-Gurevich, Giulio Innamorati, et al.
Nature Communications|August 9, 2025
Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patientsTravis W Moore, Elias Spiliotopoulos, Rowan L Callahan, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 22, 2025
HMG Box-containing Protein 1 (HBP1) Protects Against Pancreatic Injury in Acute Pancreatitis but Promotes Neoplastic ProgressionSeung-Won Lee, Taelor Ekstrom, Elise C Manalo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2025
Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug ConjugateHiroki Ozawa, Kazuki Takahashi, Tomoki Motegi, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Long Noncoding RNAs Preserve Pancreatic Cancer Identity and Resist Cell Fate ConversionDmytro Grygoryev, Seung-Won Lee, Connor Mitchell Frankston, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacyCanping Chen, Kyle P Gribbin, Xi Li, et al.
Cancer Research Communications|May 21, 2026
Increased glucose availability sensitizes pancreatic cancer to macrophage-targeting immunotherapiesJonathan J Hue, Mehrdad Zarei, Priyashree Sunita, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 8, 2026
Liquid Biopsy Differentiation of Pancreatic Cancer From Non-Cancerous Pancreatic Disease Using Dielectrophoresis-Recovered Nanoparticles Carrying Cell-Free DNA and Protein BiomarkersAnna Malakian, Augusta Modestino, Jesus Bueno, et al.
Cancers|February 15, 2022
Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative ComplicationsChristopher Ryan Deig, Thomas Lee Sutton, Blake Beneville, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
JCO Precision Oncology|May 26, 2021
Tumor-Infiltrating Leukocyte Phenotypes Distinguish Outcomes in Related Patients With Pancreatic AdenocarcinomaJason M Link, Shannon M Liudahl, Courtney B Betts, et al.
International Journal of Cancer|June 16, 2026
Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE ConsortiumChristine Worthington, Maria Raitses-Gurevich, Giulio Innamorati, et al.
Nature Communications|August 9, 2025
Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patientsTravis W Moore, Elias Spiliotopoulos, Rowan L Callahan, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 22, 2025
HMG Box-containing Protein 1 (HBP1) Protects Against Pancreatic Injury in Acute Pancreatitis but Promotes Neoplastic ProgressionSeung-Won Lee, Taelor Ekstrom, Elise C Manalo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2025
Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug ConjugateHiroki Ozawa, Kazuki Takahashi, Tomoki Motegi, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Long Noncoding RNAs Preserve Pancreatic Cancer Identity and Resist Cell Fate ConversionDmytro Grygoryev, Seung-Won Lee, Connor Mitchell Frankston, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacyCanping Chen, Kyle P Gribbin, Xi Li, et al.
Cancer Research Communications|May 21, 2026
Increased glucose availability sensitizes pancreatic cancer to macrophage-targeting immunotherapiesJonathan J Hue, Mehrdad Zarei, Priyashree Sunita, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 8, 2026
Liquid Biopsy Differentiation of Pancreatic Cancer From Non-Cancerous Pancreatic Disease Using Dielectrophoresis-Recovered Nanoparticles Carrying Cell-Free DNA and Protein BiomarkersAnna Malakian, Augusta Modestino, Jesus Bueno, et al.
Cancers|February 15, 2022
Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative ComplicationsChristopher Ryan Deig, Thomas Lee Sutton, Blake Beneville, et al.
Pageof 3